For the Inventor, By the Inventor

Enter assignee name

Beer Sheva, Israel

The National Institute for Biotechnology in the Negev Ltd.

USPTO Granted Patents = 27

EPO Patents = 8

Forward Citations = 7

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Varda Shoshan-Barmatz (13 out of 18 patents)

Arie Lev Gruzman (5 out of 5 patents)

Ari-Angel Porgador (3 out of 4 patents)

4. Roee Atlas (3 out of 3 patents)

5. Raz Zarivach (2 out of 4 patents)

6. David Ben-Menahem (2 out of 2 patents)

7. Noam Levaot (2 out of 2 patents)

8. Yuval Zur (2 out of 2 patents)

9. Lior Rosenfeld (2 out of 2 patents)

10. Amir Aharoni (2 out of 3 patents)

11. Marianna Zaretzky (2 out of 2 patents)

12. Michael M Meijler (2 out of 3 patents)

13. Josep Rayo (2 out of 2 patents)

14. Neri Amara (2 out of 2 patents)

15. Yakov Krelin (2 out of 2 patents)

27 patents: Sort by Forward Citations

1. 12408637 - Compositions for inoculating aquatic animals (2025-09-09),

2. 12098202 - Non-cytotoxic modified cells and use thereof (2024-09-24),

3. 11976280 - SMAC/Diablo inhibitors useful for treating cancer (2024-05-07),

4. 11976099 - Compositions and methods for treatment of bone associated diseases (2024-05-07),

5. 11911443 - Fusion proteins with extended serum half life (2024-02-27),

6. 11667700 - Anti-PCNA monoclonal antibodies and use thereof (2023-06-06),

7. 11634465 - Analogues of VDAC1-derived peptides (2023-04-25),

8. 11555192 - SMAC/Diablo inhibitors useful for treating cancer (2023-01-17),

9. 11472777 - Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction (2022-10-18),

10. 11408887 - Biomarkers for diagnosis of lung cancer (2022-08-09),

11. 11286533 - Biomarkers of chronic lymphocytic leukemia and use thereof (2022-03-29),

12. 11174484 - Means and methods for reducing tumorigenicity of cancer stem cells (2021-11-16),

13. 11141463 - Fusion proteins with extended serum half life (2021-10-12),

14. 11098091 - Compositions and methods for treatment of bone associated diseases (2021-08-24),

15. 10946013 - Methods for treating central nervous system disorders using vdac inhibitors (2021-03-16),

The National Institute for Biotechnology in the Negev Ltd. (NIBN) is a leading research institute in the field of biotechnology located in Beer-Sheva, Israel. The institute focuses on multidisciplinary research, combining biology, chemistry, physics, and engineering to advance scientific knowledge and develop innovative technologies. NIBN collaborates with academic institutions, industries, and hospitals to drive translational research and promote the commercialization of biotechnological solutions for various sectors, including healthcare, agriculture, and the environment. With state-of-the-art facilities and a team of renowned scientists, NIBN aims to transform scientific discoveries into practical applications that benefit society and contribute to economic growth.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

27 Patents

#6 in Beer Sheva

#206 in Israel

#23,254 in the World

Beer Sheva, Israel

The National Institute for Biotechnology in the Negev Ltd.

Forward Citations = 7

31 inventors:

Varda Shoshan-Barmatz (13 out of 18 patents)

Arie Lev Gruzman (5 out of 5 patents)

Ari-Angel Porgador (3 out of 4 patents)

4. Roee Atlas (3 out of 3 patents)

5. Raz Zarivach (2 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…